Shanghai Medicilon Inc. (SHA:688202)

Shanghai Medicilon Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	262.59	260.53	471.87	197.13	412.37	465.95
Short-Term Investments	283.98	178.76	-	-	-	-
Trading Asset Securities	208.83	261.22	518.23	-	100	-
Cash & Short-Term Investments	755.41	700.52	990.1	197.13	512.37	465.95
Cash Growth	16.62%	-29.25%	402.25%	-61.52%	9.96%	-26.77%
Accounts Receivable	574.4	598.26	671.88	575.77	250.3	172.6
Other Receivables	19.66	18.04	3.05	3.06	1.61	3.28
Receivables	594.06	616.31	674.93	578.83	251.91	175.88
Inventory	76	104.36	165.52	171.12	83.48	32.69
Other Current Assets	23.91	14.51	45.64	125.54	44.28	24.77
Total Current Assets	1,449	1,436	1,876	1,073	892.04	699.29
Property, Plant & Equipment	763.74	810.18	849.97	763.66	554.59	353.94
Long-Term Investments	193.12	151.14	100.39	10.14	-	-
Other Intangible Assets	273.78	278.15	286.9	294.05	231.61	235.02
Long-Term Deferred Tax Assets	57.5	49.95	4.77	16.96	10.8	10.04
Long-Term Deferred Charges	95.1	97.49	144.07	148.45	65.44	57.39
Other Long-Term Assets	1.38	0.65	3.55	23.69	39.09	8.65
Total Assets	2,834	2,823	3,266	2,330	1,794	1,364
Accounts Payable	126.95	144.5	190.24	218.3	120.1	87.08
Accrued Expenses	45.83	49.59	49.63	50.02	53.09	41.01
Short-Term Debt	282.15	292.24	349.39	229.41	-	-
Current Portion of Long-Term Debt	0.15	0.02	-	-	-	-
Current Portion of Leases	17.97	12.15	19.21	19.78	13.3	-
Current Income Taxes Payable	-	-	-	-	10.15	3.99
Current Unearned Revenue	52.33	64.99	62.6	85.51	152.3	53.9
Other Current Liabilities	11.35	12.65	15.29	14.02	34.72	10.16
Total Current Liabilities	536.73	576.15	686.36	617.04	383.66	196.14
Long-Term Debt	131.05	21	-	-	-	-
Long-Term Leases	17.39	20.67	14.28	25.71	30.26	-
Long-Term Unearned Revenue	55.62	57.44	49.34	40.18	29.98	23.28
Long-Term Deferred Tax Liabilities	0.03	0.14	5.09	43.87	22.16	9.25
Other Long-Term Liabilities	8.82	7.71	-	-	-	-
Total Liabilities	749.64	683.1	755.07	726.8	466.06	228.67
Common Stock	134.67	134.67	134.67	87.02	62.08	62
Additional Paid-In Capital	1,662	1,662	1,662	714.74	717.57	756.61
Retained Earnings	390.15	403.05	733.9	801.04	547.86	304.7
Treasury Stock	-102.79	-59.99	-19.99	-	-	-
Comprehensive Income & Other	0.2	0.31	0.09	-0.01	-	-
Total Common Equity	2,084	2,140	2,511	1,603	1,328	1,123
Minority Interest	-	-	-	-	-	12.34
Shareholders' Equity	2,084	2,140	2,511	1,603	1,328	1,136
Total Liabilities & Equity	2,834	2,823	3,266	2,330	1,794	1,364
Total Debt	448.71	346.08	382.88	274.9	43.56	-
Net Cash (Debt)	306.69	354.44	607.22	-77.76	468.8	465.95
Net Cash Growth	-24.66%	-41.63%	-	-	0.61%	-26.77%
Net Cash Per Share	2.34	2.65	4.75	-0.64	3.86	3.84
Filing Date Shares Outstanding	131.87	133.67	134.67	121.82	121.68	121.52
Total Common Shares Outstanding	131.87	133.67	134.67	121.82	121.68	121.52
Working Capital	912.64	859.55	1,190	455.59	508.37	503.15
Book Value Per Share	15.81	16.01	18.64	13.16	10.91	9.24
Tangible Book Value	1,811	1,862	2,224	1,309	1,096	888.29
Tangible Book Value Per Share	13.73	13.93	16.51	10.74	9.01	7.31
Buildings	178.31	178.31	178.31	178.31	179.66	177.39
Machinery	806.49	810.44	797.29	626.44	410	313.12
Construction In Progress	161.28	169.19	142.71	140.39	100.62	10.83

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.